Allied Corp Files for Full Psilocybin Patent for Psilonex™ Rx Pharmaceutical
March 16, 2022 08:55 ET
|
Allied Corp.
KELOWNA, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has successfully filed for a full patent regarding...
Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process
September 10, 2021 08:55 ET
|
Allied Corp.
KELOWNA, British Columbia, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has initiated the manufacturing activities for...
Allied Corp Increases Intellectual Property Protection by Filing Trademark for Pharma Product PSILONEX
March 25, 2021 08:55 ET
|
Allied Corp.
KELOWNA, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health...